Personalising Innate-immunotherapy for Superior Treatment Outcomes with Large anticancer applicability (PISTOL) (2023–2026)
- Grant type:
- NHMRC MRFF EMCR - Early to Mid-Career Researchers
- Researchers:
-
-
Principal Research Fellow
Frazer InstituteFaculty of MedicineAffiliate Senior Research Fellow
School of Biomedical SciencesFaculty of Medicine -
Principal Research Fellow
School of Chemical EngineeringFaculty of Engineering, Architecture and Information TechnologyGroup Leader
Australian Institute for Bioengineering and Nanotechnology -
-
-
-
-
HERA - Senior Research Fellow
Australian Institute for Bioengineering and Nanotechnology -
Principal Research Fellow
Frazer InstituteFaculty of Medicine -
-
- Funded by:
- Commonwealth Department of Health and Aged Care
